| Income Statement |
| Total Revenue | 68.83M |
|
| Revenues (USD) | 68.83M |
| Cost of Revenue | 62.96M |
| Gross Profit | 5.87M |
| Operating Expenses | 36.68M |
| Research and Development Expense | 4.19M |
| Selling, General and Administrative Expense | 32.49M |
| Operating Income | -30.81M |
| Interest Expense | 6.57M |
| Net Income | 16.40M |
| Net Income Common Stock | 16.40M |
| Net Income Common Stock (USD) | 16.40M |
| Consolidated Income | 16.40M |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | -0.06 |
| Earning Before Interest & Taxes (EBIT) | 22.98M |
| Earning Before Interest & Taxes (USD) | 22.98M |
| Weighted Average Shares | 501.30M |
| Weighted Average Shares Diluted | 591.87M |
| Balance Sheet |
| Cash and Equivalents | 176.89M |
| Cash and Equivalents (USD) | 176.89M |
| Investments | 10.74M |
| Investments Non-Current | 10.74M |
| Trade and Non-Trade Receivables | 25.73M |
| Current Assets | 295.65M |
| Property, Plant & Equipment Net | 206.29M |
| Total Assets | 559.85M |
| Debt Current | 35.62M |
| Total Debt | 426.25M |
| Current Liabilities | 112.24M |
| Debt Non-Current | 390.63M |
| Total Liabilities | 503.10M |
| Accumulated Retained Earnings (Deficit) | -1.03B |
| Accumulated Other Comprehensive Income | -4.78M |
| Shareholders Equity | 56.76M |
| Shareholders Equity (USD) | 56.76M |
| Assets Non-Current | 264.20M |
| Total Debt (USD) | 426.25M |
| Inventory | 63.13M |
| Liabilities Non-Current | 390.85M |
| Trade and Non-Trade Payables | 25.02M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.22M |
| Net Cash Flow from Financing | -2.12M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.09M |
| Capital Expenditure | -566.00K |
| Issuance (Repayment) of Debt Securities | -1.82M |
| Net Cash Flow from Investing | -513.00K |
| Net Cash Flow from Operations | -18.13M |
| Effect of Exchange Rate Changes on Cash | 1.14M |
| Share Based Compensation | 7.40M |